American College of Clinical Pharmacy
      Search      Cart
         

Clinical Reasoning Series in Critical Care Pharmacy, 2018 Home Study Edition





The 2018 PADIS Guideline: Boosting Efforts to Reduce Pain, Oversedation, Delirium, Immobility and Disrupted Sleep in the ICU

 

Series Overview

 

Clinical Reasoning Series is one component of the professional development program developed by ACCP and approved for the recertification by the Board of Pharmacy Specialties (BPS) for the recertification of Board Certified Critical Care Pharmacists (BCCCPs) and Board Certified Pharmacotherapy Specialists (BCPSs).

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

Program Content

“The 2018 PADIS Guideline: Boosting Efforts to Reduce Pain, Oversedation, Delirium, Immobility and Disrupted Sleep in the ICU” will provide an in-depth analysis of current strategies for the management of protocols for mobilization and rehabilitation, as well as, promoting quality sleep in the ICU. It is important to understand the role of the pharmacist in optimal patient care as practices continue to advance. The content of this session expands upon the new 2018 PADIS guidelines and provides practical approaches to implementation.

“The 2018 PADIS Guideline: Boosting Efforts to Reduce Pain, Oversedation, Delirium, Immobility and Disrupted Sleep in the ICU” covers the following content:

  • PADIS Guideline Methods: Innovation and Interpretation Considerations
  • PADIS Guideline: Informing ABCDEF Bundle Use and Quality Improvement Efforts
  • Comfort is King: A Protocolized Approach to Pain Recognition and Multimodal Treatment
  • Strategies to Maintain Patient Wakefulness
  • Delirium Recognition and Reduction: Reducing the Confusion
  • Creating a Culture of Rehabilitation and Mobilization
  • Improving Sleep Quality in the Critically Ill
Faculty
Mary Ann Barnes-Daly MS, RN, CCRN-K, DC Mary Ann Barnes-Daly MS, RN, CCRN-K, DC
Clinical Performance Improvement Specialist Sutter Health Sacramento, California Co-chair, SCCM ICU Liberation Committee
John W. Devlin. PharmD, BCCCP, FCCP, FCCM John W. Devlin. PharmD, BCCCP, FCCP, FCCM
Professor of Pharmacy, Northeastern University
Scientific Staff, Division of Pulmonary, Critical Care and Sleep Medicine
Tufts Medical Center, Boston, Massachusetts
Gil Fraser, PharmD, MCCM Gil Fraser, PharmD, MCCM
Professor of Medicine, Tufts University
Critical Care Pharmacist
Maine Medical Center
Portland, Maine
Rob MacLaren, PharmD, MPH, FCCM, FCCP Rob MacLaren, PharmD, MPH, FCCM, FCCP
Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado

 

Target Audience and Program Goals

 

Clinical Pharmacists, BCCCPs, and BCPSs providing care to patients with pain, oversedation, delirium, immobility and disrupted sleep in the ICU

 

At the conclusion of the program, the participant should be able to:

 

  1. Articulate the advancements in pain, agitation, delirium, mobility and sleep practices in the critically ill.
  2. Critically appraise the published evidence on the treatment of patients with pain, agitation, delirium, immobility and sleep disturbances.
  3. Propose alterations in your institutions’ current protocols for pain, agitation and delirium management.
  4. Prepare evidence-based protocols reflective of practice advancement for pain, agitation, delirium, mobility and sleep.
  5. Employ patient-centered strategies to advance care processes, including quality assurance and process improvement.

 

Continuing Pharmacy Education Credit

 

ACPE The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is an application-based activity; Activity Number: 0217-0000-18-167-H01-P.

 

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 22, 2021. Partial credit is not available for this activity.

 

BCCCP and BCPS Specialty Recertification Credit

To be eligible for 6.0 CPE hours of recertification credit, BCCCPs and BCPSs must attend all 6.0 contact hours of live programming and successfully complete a Web‐based posttest by December 31, 2018. Partial credit is not available for this activity.

 

ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS.

 

Technical Requirements

Requires an Internet browser and Adobe Reader.
 

Fees
Description Price Nonmember Cart
Specialty Recertification Program with 6.0 Continuing Education Credits
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
Test submission deadline for recertification is December 31, 2018.
$250 $365
Online Program with 6.0 Continuing Education Credits (CPE only)
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed. under Continuing Pharmacy Education Credit above.
This product does not include specialty recertification credit. Test submission deadline for CPE credit is October 22, 2021.
$199 $315